Victory Capital Management Inc Biora Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 10, 2023	BUY	$0.13 - $12.03 $2,450 - $226,765	18,850 New	18,850 $2,000
Q3 2022 Nov 02, 2022	SELL	$0.53 - $13.3 $2,622 - $65,808	-4,948 Reduced 20.78%	18,858 $9,000
Q2 2022 Aug 01, 2022	SELL	$0.56 - $1.22 $85 - $185	-152 Reduced 0.63%	23,806 $17,000
Q1 2022 May 04, 2022	BUY	$1.11 - $2.25 $2,531 - $5,132	2,281 Added 10.52%	23,958 $20,000
Q4 2021 Feb 07, 2022	BUY	$1.35 - $4.89 $10,161 - $36,807	7,527 Added 53.19%	21,677 $45,000
Q3 2021 Nov 02, 2021	BUY	$0.67 - $3.41 $9,480 - $48,251	14,150 New	14,150 $22,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $299M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.